Archives

Protease-activated receptor-2 protects against influenza virus through IFN-gamma pathway

Pathways:

IFN-gamma pathway

Host Molecules Involved:

Protease-activated receptor-2 (PAR(2)), associated with inflammation at mucosal surfaces.

Tissues:

Respiratory tract, mucosal surfaces, bronchoalveolar lavages

Systems:

Lungs, immune system

Interactions:

PAR(2) enhances IFN- gamma production.

Mechanisms:

In vitro, PAR(2) inhibits influenza virus type A (IAV) replication through the production of IFN-gamma.
In [...]

SFTPD

Gene:

SFTPD

Full Name:

surfactant protein D [Homo sapiens]

Other Symbols:

COLEC7, PSP-D, SFTP4, SP-D

Other Names:

collectin 7; pulmonary surfactant apoprotein; pulmonary surfactant-associated protein D; surfactant, pulmonary-associated protein D; surfactant-associated protein, pulmonary 4

Chromosome Location:

10q22.2-q23.1

OMIMID:

178635

GeneID:

6441

Sequences:

Nucleotide
Protein

Human-Influenza Interactions:

- An extended ligand binding site is found for mannosylated ligands on SFTPD, with [...]

Host-Virus-Vaccine (Human-Influenza-Vaccine) Interaction Genes: CCL11

Symbol:

CCL11

Name:

chemokine (C-C motif) ligand 11 [Homo sapiens]

Other Symbols:

MGC22554, SCYA11

Other Names:

eosinophil chemotactic protein; eotaxin-1; small inducible cytokine A11; small inducible cytokine subfamily A (Cys-Cys), member 11 (eotaxin)

Chromosome Location:

17q21.1-q21.2

OMIMID:

601156

GeneID:

6356

Sequences:

Nucleotide

Protein

Family:

Cytokines

Function:

Chemotactic activity for eosinophils; associated with eosinophilic inflammatory diseases, e.g., atopic dermatitis, allergic rhinitis, asthma [...]

Copyright © 2009 PharmTao.com. All Rights Reserved.
Disclaimer: By using this site, the readers agree that the content on our web pages is for information purpose only. The information provided on our web pages is not intended for diagnosis, or to treat, cure or prevent any diseases, conditions or symptoms, or to do experiments, or to endorse any products. Personal directions and the use of health and biomedical products should be provided by qualified health professionals.